BALA CYNWYD, Pa., March 05, 2025 (GLOBE NEWSWIRE) — Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.
Chimerix, Inc. (Nasdaq – CMRX)
Under the terms of the agreement, Chimerix will be acquired by Jazz Pharmaceuticals plc (“Jazz”) (Nasdaq – JAZZ) for $8.55 per share in cash for each Chimerix share, representing a total consideration of approximately $935 million. The investigation concerns whether the Chimerix Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether the Company’s shareholders are receiving fair value for their shares.
Additional information can be found at https://www.brodskysmith.com/cases/chimerix-inc-nasdaq-cmrx/.
Siyata Mobile Inc. (Nasdaq – SYTA)
Under the terms of the agreement, Siyata will be acquired by Core Gaming, Inc. (“Core Gaming”). In exchange for the outstanding shares …
